Back to today’s briefing

Story perspectives

Trump Nominates Heidi Overton as FDA Commissioner

8/19/2026

33 4 Full Breakdown

Center

Trump Nominates Overton

U.S. President Donald Trump officially nominated Heidi Overton as commissioner of the Food and Drug Administration on August 18, 2026.
Overton helped lead the administration’s response to the 2026 Central Africa Ebola epidemic.
The FDA lost over 3,000 staff in the past year, prompting significant calls to restore confidence.
White House Domestic Policy Council deputy director Overton attended Trump’s MMR split order announcement.

Left

Trump Nominates

U.S. President Donald Trump nominated Dr. Heidi Overton as commissioner of the Food and Drug Administration on August 18, 2026.
Overton has warned that abortion medication is far more dangerous to women and urged the FDA to impose stricter restrictions.
The FDA is dealing with high staff turnover and political interference.
She backed an executive order curbing childhood vaccinations, sparking a contentious Senate health committee hearing.

Blindspot

Blindspot

Overton said abortion medication is “far more dangerous to women” and urged stricter FDA restrictions on the pills.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Center-leaning coverage.

History

Historical Context

The FDA’s modern safety regime traces back to the 2004 voluntary withdrawal of Merck’s Vioxx, approved in 1999, which spurred the 2006 Institute of Medicine report and the 2007 Food and Drug Administration Amendments Act. Today, President Donald Trump’s 2026 nomination of Heidi Overton to lead an agency facing a 3,000-staff shortfall revives those post-Vioxx oversight concerns while targeting mifepristone restrictions.

1 of 4

Trump Nominates Overton

U.S. President Donald Trump officially nominated Heidi Overton as commissioner of the Food and Drug Administration on August 18, 2026.
Overton helped lead the administration’s response to the 2026 Central Africa Ebola epidemic.
The FDA lost over 3,000 staff in the past year, prompting significant calls to restore confidence.
White House Domestic Policy Council deputy director Overton attended Trump’s MMR split order announcement.

1 / 4